What if error risk could embrace uncertainty?

2021 ◽  
pp. 1-17
Author(s):  
Erwann Kerguelen
Keyword(s):  
2014 ◽  
Vol 30 ◽  
pp. 113-123 ◽  
Author(s):  
Lijing Wang ◽  
Yanlong Wang ◽  
Qiyan Cao ◽  
Xiaodong Li ◽  
Jinquan Li ◽  
...  

2001 ◽  
Vol 36 (5) ◽  
pp. 494-496
Author(s):  
Michael R. Cohen

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them in your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the USP Medication Errors Reporting Program, which is presented in cooperation with the Institute for Safe Medication Practices. If you have encountered medication errors and would like to report them, you may call USP toll-free, 24 hours a day, at 1-800-233-7767 (1-800-23-ERROR). Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below.


2020 ◽  
Vol 12 (13) ◽  
pp. 5458 ◽  
Author(s):  
Valentin-Marian Antohi ◽  
Monica Laura Zlati ◽  
Romeo Victor Ionescu ◽  
Mihaela Neculita ◽  
Raluca Rusu ◽  
...  

Against the backdrop of Romania’s successive negative performance in attracting European funds (coming last in the EU top), as indicated by audit reports for projects that have been funded so far, this paper proposes a new approach in relation to analysis and performance improvement in securing EU funds, while identifying viable solutions for the betterment of the current situation. Furthermore, the authors develop a new audit performance analysis model (NOP), described as a dynamic and flexible model, based on reducing the fraud and error risk in the structural fund management of European-funded projects. The analysis methods encompass literature reviews, observational studies, database management, statistical analysis, and the synthesis of the whole findings. The main conclusion of the analysis is the critical necessity of integrity improvement in the context of managing the non-reimbursable funds through audit activities based on ISA805, the international standard on auditing European-funded projects.


2004 ◽  
Vol 7 (1) ◽  
pp. 61-77 ◽  
Author(s):  
Dominiek Sandra ◽  
Steven Frisson ◽  
Frans Daems

We review some of our research findings on verb spelling errors in Dutch. The spelling of Dutch regularly inflected verb forms is governed by rules of the simple concatenative type (stem + suffix). The spelling of a subset of these verb forms is determined by morpheme-based analogy, both at the level of the stem-final letter and at the level of the inaudible (i.e., silent) suffix. This subset of verb forms causes many spelling problems, both in the learning stage and in the spelling process of experienced spellers. Our research identifies two sources of these errors. First, the error risk results from the time-consuming nature of the cognitive operations needed for spelling the silent suffix. Second, the errors follow a particular pattern: the typical error is a homophonic verb spelling form which has a higher frequency of occurrence in the Dutch written language than the target form. This homophone frequency effect shows that regularly inflected verb forms with silent suffixes have their own orthographic representation in the mental lexicon, even though they are fully predictable by rule.


2007 ◽  
Vol 46 (06) ◽  
pp. 655-661 ◽  
Author(s):  
H. Heinzl ◽  
A. Benner ◽  
C. Ittrich ◽  
M. Mittlböck

Summary Objectives : Numerous sample size calculation programs are available nowadays. They include both commercial products as well as public domain and open source applications. We propose modifications for these programs in order to even better support statistical consultation during the planning stage of a two-armed clinical trial. Methods : Directional two-sided tests are commonly used for two-armed clinical trials. This may lead to a non-negligible Type III error risk in a severely underpowered study. In the case of a reasonably sized study the question for the so-called auxiliary alternative may evolve. Results : We propose that sample size calculation programs should be able to compute i) Type III errors and the so-called (q-values, ii) minimum sample sizes required to keep the (q-values below pre-specified levels, and iii) detectable effect sizes of the so-called auxiliary alternatives. Conclusions : Proposals iand ii are intended to help prevent irresponsibly underpowered clinical trials, whereas the proposal iii is meant as additional assistance for the planning of reasonably sized clinical trials.


Sign in / Sign up

Export Citation Format

Share Document